martes, 11 de abril de 2017

Ribociclib - National Cancer Institute

Ribociclib - National Cancer Institute

National Cancer Institute


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
This page contains brief information about ribociclib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA Approved

Use in Cancer

Ribociclib is approved to be used with an aromatase inhibitor to treat:
Ribociclib is also being studied in the treatment of other types of cancer.

More About Ribociclib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Clinical Trials Accepting Patients

Find Clinical Trials for Ribociclib - Check for trials from NCI's list of cancer clinical trials now accepting patients.
  • Posted: March 16, 2017

No hay comentarios:

Publicar un comentario